Lipid metabolism and hormonal interactions: impact on cardiovascular disease and healthy aging

References

• WHO, US National Institute of Aging. Global health and ageing. WHO; Geneva: 2011
   Google Scholar
• Amaranayake N, Church J, Hill C, et al. Social trends 30: office for national statistics. The stationary office; London, UK: 2000
   Google Scholar
• Statistical bulletin. Life expectancy at birth and at age 65 for local areas in England and Wales, 2010-12. Office for National Statistics; UK: 2013
   Google Scholar
• Beaumont J. Population social trends 41, O.f.N. Statistics. Office for National Statistics; UK: 2011
   Google Scholar
• Shrestha LB, Heisler EJ. The changing demographic profile of the United States. CRS; USA: 2011. p. 1-21
   Google Scholar
• UN. World population prospects the 2012 revision. Volume 2. Demographic profiles. E.S. Affairs; United Nations, NY, USA: 2013
   Google Scholar
• Age UK. Improving later life. Understanding the oldest old. Age UK; UK: 2013
   Google Scholar
• Alemayehu B, Warner KE. The lifetime distribution of health care costs. Health Serv Res 2004;39(3):627-42
   PubMed Web of Science ®Google Scholar
• Campbell JC, Ikegami N. Long-term care insurance comes to Japan. Health Aff (Millwood) 2000;19(3):26-39
   PubMed Web of Science ®Google Scholar
• Public Health England. Chronic disease prevalence by age, sex SHA and UK country in 2008. 2013. Available from: www.gov.uk/government/organisations/public-health-england
   Google Scholar
• Scarborough P, Wickramasinghe K, Bhatnagar P, Rayner M. Trends in coronary heart disease, 1961-2011. B.H. Foundation; London, UK: 2011
   Google Scholar
• Townsend N, Wickramasinghe K, Bhatnagar P, et al. Coronary heart disease statistics A compendium of health statistics. British Heart Foundation; London, UK: 2012
   Google Scholar
• Tattersall MC, Gangnon RE, Karmali KN, et al. Trends in low-density lipoprotein cholesterol goal achievement in high risk United States adults: longitudinal findings from the 1999-2008 National Health and Nutrition Examination Surveys. PLoS One 2013;8(4):e59309
   Google Scholar
• Arai H. Oxidative modification of lipoproteins. Subcell Biochem 2014;77:103-14
   PubMedGoogle Scholar
• Assmann G, Cullen P, Schulte H. The Munster Heart Study (PROCAM). Results of follow-up at 8 years. Eur Heart J 1998;19(Suppl A):A2-11
   PubMedGoogle Scholar
• Cooney MT, Dudina A, De Bacquer D, et al. HDL cholesterol protects against cardiovascular disease in both genders, at all ages and at all levels of risk. Atherosclerosis 2009;206(2):611-16
   PubMedGoogle Scholar
• Ginter E, Simko V. New promising potential in fighting atherosclerosis: HDL and reverse cholesterol transport. Bratisl Lek Listy 2013;114(3):172-6
   PubMedGoogle Scholar
• McAuley MT, Wilkinson DJ, Jones JJ, Kirkwood TB. A whole-body mathematical model of cholesterol metabolism and its age-associated dysregulation. BMC Syst Biol 2012;6(1):130
   PubMedGoogle Scholar
• McAuley MT, Proctor CJ, Cofe BM, et al. Nutrition research and the impact of computational systems Biology. J Comput Sci Syst Biol 2013;6:271-85
   Google Scholar
• Sarwar N, Danesh J, Eiriksdottir G, et al. Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies. Circulation 2007;115(4):450-8
   PubMed Web of Science ®Google Scholar
• Schwartz EA, Reaven PD. Lipolysis of triglyceride-rich lipoproteins, vascular inflammation, and atherosclerosis. Biochim Biophys Acta 2012;1821(5):858-66
   PubMedGoogle Scholar
• Langin D. Adipose tissue lipolysis as a metabolic pathway to define pharmacological strategies against obesity and the metabolic syndrome. Pharmacol Res 2006;53(6):482-91
   PubMed Web of Science ®Google Scholar
• Dinel AL, Kolditz C, Langin D. Metabolism of fatty acids in adipocytes. In: Christen Y, Clément K, Spiegelman BM, editors. Novel insights into adipose cell functions. Springer Berlin Heidelberg; Berlin, Germany: 2010. p. 21-43
   Google Scholar
• Lass A, Zimmermann R, Oberer M, Zechner R. Lipolysis - a highly regulated multi-enzyme complex mediates the catabolism of cellular fat stores. Prog Lipid Res 2011;50(1):14-27
   PubMed Web of Science ®Google Scholar
• Zechner R, Kienesberger PC, Haemmerle G, et al. Adipose triglyceride lipase and the lipolytic catabolism of cellular fat stores. J Lipid Res 2009;50(1):3-21
   PubMed Web of Science ®Google Scholar
• Kraemer FB, Shen WJ. Hormone-sensitive lipase knockouts. Nutr Metab (Lond) 2006;3:12
   PubMedGoogle Scholar
• Reaven G. Insulin resistance and coronary heart disease in nondiabetic individuals. Arterioscler Thromb Vasc Biol 2012;32(8):1754-9
   PubMed Web of Science ®Google Scholar
• Reaven GM. Insulin resistance: the link between obesity and cardiovascular disease. Med Clin North Am 2011;95(5):875-92
   PubMed Web of Science ®Google Scholar
• McAuley MT, Kenny RA, Kirkwood TB, et al. A mathematical model of aging-related and cortisol induced hippocampal dysfunction. BMC Neurosci 2009;10:26
   PubMed Web of Science ®Google Scholar
• Peckett AJ, Wright DC, Riddell MC. The effects of glucocorticoids on adipose tissue lipid metabolism. Metabolism 2011;60(11):1500-10
   PubMed Web of Science ®Google Scholar
• Park SY, Bae JH, Cho YS. Cortisone induces insulin resistance in C2C12 myotubes through activation of 11beta-hydroxysteroid dehydrogenase 1 and autocrinal regulation. Cell Biochem Funct 2014;32(3):249-57
   PubMedGoogle Scholar
• Howlett TA, Rees LH, Besser GM. Cushing’s syndrome. Clin Endocrinol Metab 1985;14(4):911-45
   PubMedGoogle Scholar
• Rosmond R, Bjorntorp P. The hypothalamic-pituitary-adrenal axis activity as a predictor of cardiovascular disease, type 2 diabetes and stroke. J Intern Med 2000;247(2):p.188-97
   PubMed Web of Science ®Google Scholar
• Knoops AJ, van der Graaf Y, Mali WP, Geerlings MI. Age-related changes in hypothalamic-pituitary-adrenal axis activity in patients with manifest arterial disease. Endocrine 2010;37(1):231-8
   PubMedGoogle Scholar
• Jokinen J, Nordstrom P. HPA axis hyperactivity and cardiovascular mortality in mood disorder inpatients. J Affect Disord 2009;116(1-2):88-92
   PubMed Web of Science ®Google Scholar
• Jiang YZ, Xing SH, Cen WM, et al. [New insights in regulation factors of lipoprotein lipase]. Yi Chuan 2013;35(7):830-8
   PubMedGoogle Scholar
• Samra JS, Clark ML, Humphreys SM, et al. Effects of physiological hypercortisolemia on the regulation of lipolysis in subcutaneous adipose tissue. J Clin Endocrinol Metab 1998;83(2):626-31
   PubMedGoogle Scholar
• Sakayama K, Mashima N, Kidani T, et al. Effect of cortisol on cell proliferation and the expression of lipoprotein lipase and vascular endothelial growth factor in a human osteosarcoma cell line. Cancer Chemother Pharmacol 2008;61(3):471-9
   PubMedGoogle Scholar
• Pedersen SB, Jonler M, Richelsen B. Characterization of regional and gender differences in glucocorticoid receptors and lipoprotein lipase activity in human adipose tissue. J Clin Endocrinol Metab 1994;78(6):1354-9
   PubMed Web of Science ®Google Scholar
• Casanovas A, Parramon N, de la Cruz F, et al. Retroperitoneal white adipose tissue lipoprotein lipase activity is rapidly down-regulated in response to acute stress. J Lipid Res 2007;48(4):863-8
   PubMedGoogle Scholar
• Park SB, Blumenthal JA, Lee SY, Georgiades A. Association of cortisol and the metabolic syndrome in Korean men and women. J Korean Med Sci 2011;26(7):914-18
   PubMedGoogle Scholar
• Ward AM, Fall CH, Stein CE, et al. Cortisol and the metabolic syndrome in South Asians. Clin Endocrinol (Oxf) 2003;58(4):500-5
   PubMedGoogle Scholar
• Xu C, He J, Jiang H, et al. Direct effect of glucocorticoids on lipolysis in adipocytes. Mol Endocrinol 2009;23(8):1161-70
   PubMedGoogle Scholar
• Djurhuus CB, Gravholt CH, Nielsen S, et al. Additive effects of cortisol and growth hormone on regional and systemic lipolysis in humans. Am J Physiol Endocrinol Metab 2004;286(3):E488-94
   Google Scholar
• Pedersen SB, Bak JF, Holck P, et al. Epinephrine stimulates human muscle lipoprotein lipase activity in vivo. Metabolism 1999;48(4):461-4
   PubMedGoogle Scholar
• Carmen GY, Victor SM. Signalling mechanisms regulating lipolysis. Cell Signal 2006;18(4):401-8
   PubMed Web of Science ®Google Scholar
• Horton TJ, Dow S, Armstrong M, Donahoo WT. Greater systemic lipolysis in women compared with men during moderate-dose infusion of epinephrine and/or norepinephrine. J Appl Physiol 2009;107(1):200-10
   PubMedGoogle Scholar
• Ong JM, Saffari B, Simsolo RB, Kern PA. Epinephrine inhibits lipoprotein lipase gene expression in rat adipocytes through multiple steps in posttranscriptional processing. Mol Endocrinol 1992;6(1):61-9
   PubMedGoogle Scholar
• Horowitz JF, Klein S. Whole body and abdominal lipolytic sensitivity to epinephrine is suppressed in upper body obese women. Am J Physiol Endocrinol Metab 2000;278(6):E1144-52
   Google Scholar
• Jocken JW, Goossens GH, van Hees AM, et al. Effect of beta-adrenergic stimulation on whole-body and abdominal subcutaneous adipose tissue lipolysis in lean and obese men. Diabetologia 2008;51(2):320-7
   PubMedGoogle Scholar
• Mowers J, Uhm M, Reilly SM, et al. Inflammation produces catecholamine resistance in obesity via activation of PDE3B by the protein kinases IKK{varepsilon} and TBK1. Elife 2013;2:e01119
   Google Scholar
• Niemi T, Nikkila EA. Effect of age on the lipemia clearing activity of serum after administration of heparin to human subjects. J Gerontol 1957;12(1):44-7
   PubMedGoogle Scholar
• Brodows RG, Campbell RG. Effect of age on post-heparin lipase. N Engl J Med 1972;287(19):969-70
   PubMed Web of Science ®Google Scholar
• Bey L, Areiqat E, Sano A, Hamilton MT. Reduced lipoprotein lipase activity in postural skeletal muscle during aging. J Appl Physiol 2001;91(2):687-92
   PubMed Web of Science ®Google Scholar
• Hamilton MT, Areiqat E, Hamilton DG, Bey L. Plasma triglyceride metabolism in humans and rats during aging and physical inactivity. Int J Sport Nutr Exerc Metab 2001;11(Suppl):S97-104
   Google Scholar
• Watts GF, Ooi EM, Chan DC. Demystifying the management of hypertriglyceridaemia. Nat Rev Cardiol 2013;10(11):648-61
   PubMed Web of Science ®Google Scholar
• Wang H, Eckel RH. Lipoprotein lipase: from gene to obesity. Am J Physiol Endocrinol Metab 2009;297(2):E271-88
   PubMed Web of Science ®Google Scholar
• Shimada M, Ishibashi S, Gotoda T, et al. Overexpression of human lipoprotein lipase protects diabetic transgenic mice from diabetic hypertriglyceridemia and hypercholesterolemia. Arterioscler Thromb Vasc Biol 1995;15(10):1688-94
   PubMedGoogle Scholar
• Jensen DR, Schlaepfer IR, Morin CL, et al. Prevention of diet-induced obesity in transgenic mice overexpressing skeletal muscle lipoprotein lipase. Am J Physiol 1997;273(2 Pt 2):R683-9
   Google Scholar
• Semenkovich CF, Wims M, Noe L, et al. Insulin regulation of lipoprotein lipase activity in 3T3-L1 adipocytes is mediated at posttranscriptional and posttranslational levels. J Biol Chem 1989;264(15):9030-8
   PubMed Web of Science ®Google Scholar
• Goldberg IJ, Eckel RH, Abumrad NA. Regulation of fatty acid uptake into tissues: lipoprotein lipase- and CD36-mediated pathways. J Lipid Res 2009;50(Suppl):S86-90
   PubMed Web of Science ®Google Scholar
• Vijayakumar A, Novosyadlyy R, Wu Y, et al. Biological effects of growth hormone on carbohydrate and lipid metabolism. Growth Horm IGF Res 2010;20(1):1-7
   PubMedGoogle Scholar
• Hermann M, Berger P. Hormonal changes in aging men: a therapeutic indication? Exp Gerontol 2001;36(7):1075-82
   PubMedGoogle Scholar
• Sattler FR. Growth hormone in the aging male. Best Pract Res Clin Endocrinol Metab 2013;27(4):541-55
   PubMedGoogle Scholar
• Ziv E, Hu D. Genetic variation in insulin/IGF-1 signaling pathways and longevity. Ageing Res Rev 2011;10(2):201-4
   PubMedGoogle Scholar
• Abbott RD, Garrison RJ, Wilson PW, et al. Joint distribution of lipoprotein cholesterol classes. The Framingham study. Arteriosclerosis 1983;3(3):260-72
   PubMedGoogle Scholar
• Miller NE. Why does plasma low density lipoprotein concentration in adults increase with age? Lancet 1984;1(8371):263-7
   PubMedGoogle Scholar
• Grundy SM, Vega GL, Bilheimer DW. Kinetic mechanisms determining variability in low density lipoprotein levels and rise with age. Arteriosclerosis 1985;5(6):623-30
   PubMedGoogle Scholar
• Ericsson S, Eriksson M, Vitols S, et al. Influence of age on the metabolism of plasma low density lipoproteins in healthy males. J Clin Invest 1991;87(2):591-6
   PubMed Web of Science ®Google Scholar
• Sniderman AD, De Graaf J, Couture P, et al. Regulation of plasma LDL: the apoB paradigm. Clin Sci (Lond) 2010;118(5):333-9
   PubMedGoogle Scholar
• Mahley RW, Innerarity TL. Lipoprotein receptors and cholesterol homeostasis. Biochim Biophys Acta 1983;737(2):197-222
   PubMedGoogle Scholar
• Segatto M, Trapani L, Marino M, Pallottini V. Age- and sex-related differences in extra-hepatic low-density lipoprotein receptor. J Cell Physiol 2011;226(10):2610-16
   PubMedGoogle Scholar
• Einarsson K, Nilsell K, Leijd B, Angelin B. Influence of age on secretion of cholesterol and synthesis of bile acids by the liver. N Engl J Med 1985;313(5):277-82
   PubMedGoogle Scholar
• Uchida K, Chikai T, Takase H, et al. Age-related changes of bile acid metabolism in rats. Arch Gerontol Geriatr 1990;10(1):37-48
   PubMedGoogle Scholar
• Uchida K, Nomura Y, Takase H, et al. Age-related changes in cholesterol and bile-acid metabolism in spontaneously hypertensive rats. Arch Gerontol Geriatr 1982;1(2):171-91
   PubMedGoogle Scholar
• Uchida K, Nomura Y, Kadowaki M, et al. Age-related changes in cholesterol and bile acid metabolism in rats. J Lipid Res 1978;19(5):544-52
   PubMedGoogle Scholar
• Corpas E, Harman SM, Blackman MR. Human growth hormone and human aging. Endocr Rev 1993;14(1):20-39
   PubMedGoogle Scholar
• Machado MO, Hirata RD, Hirata MH, et al. Growth hormone increases low-density lipoprotein receptor and HMG-CoA reductase mRNA expression in mesangial cells. Nephron Exp Nephrol 2003;93(4):e134-40
   Google Scholar
• Rudling M, Norstedt G, Olivecrona H, et al. Importance of growth hormone for the induction of hepatic low density lipoprotein receptors. Proc Natl Acad Sci USA 1992;89(15):6983-7
   PubMedGoogle Scholar
• Rudling M, Parini P, Angelin B. Growth hormone and bile acid synthesis. Key role for the activity of hepatic microsomal cholesterol 7alpha-hydroxylase in the rat. J Clin Invest 1997;99(9):2239-45
   PubMedGoogle Scholar
• Hollander D, Morgan D. Increase in cholesterol intestinal absorption with aging in the rat. Exp Gerontol 1979;14(4):201-4
   PubMed Web of Science ®Google Scholar
• Wang HH, Afdhal NH, Wang DQ. Overexpression of estrogen receptor alpha increases hepatic cholesterogenesis, leading to biliary hypersecretion in mice. J Lipid Res 2006;47(4):778-86
   PubMedGoogle Scholar
• Cao WM, Murao K, Imachi H, et al. Insulin-like growth factor-i regulation of hepatic scavenger receptor class BI. Endocrinology 2004;145(12):5540-7
   PubMedGoogle Scholar
• Leiva A, Verdejo H, Benítez ML, et al. Mechanisms regulating hepatic SR-BI expression and their impact on HDL metabolism. Atherosclerosis 2011;217(2):299-307
   PubMedGoogle Scholar
• Bengtsson BA, Edén S, Lönn L, et al. Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J Clin Endocrinol Metab 1993;76(2):309-17
   PubMed Web of Science ®Google Scholar
• Li ZP, Zhang T, Zhou GY, et al. [Serum leptin, adiponectin, visfatin levels in adult GHD patients and correlation studies]. Sichuan Da Xue Xue Bao Yi Xue Ban 2013;44(4):588-91
   PubMedGoogle Scholar
• Swarbrick MM, Havel PJ. Physiological, pharmacological, and nutritional regulation of circulating adiponectin concentrations in humans. Metab Syndr Relat Disord 2008;6(2):87-102
   PubMedGoogle Scholar
• Garten A, Schuster S, Kiess W. The insulin-like growth factors in adipogenesis and obesity. Endocrinol Metab Clin North Am 2012;41(2):283-95. v-vi
   PubMedGoogle Scholar
• Liu Y, Zhong Y, Pei J, et al. Inhibitory effect of leptin on growth hormone secretion of GH3 cells: involvement of cell proliferation, apoptosis and intracellular free Ca2+. Cytokine 2009;46(2):245-50
   PubMedGoogle Scholar
• Lim S, Quon MJ, Koh KK. Modulation of adiponectin as a potential therapeutic strategy. Atherosclerosis 2014;233(2):721-8
   PubMedGoogle Scholar
• Awazawa M, Ueki K, Inabe K, et al. Adiponectin enhances insulin sensitivity by increasing hepatic IRS-2 expression via a macrophage-derived IL-6-dependent pathway. Cell Metab 2011;13(4):401-12
   PubMed Web of Science ®Google Scholar
• Beatty AL, Zhang MH, Ku IA, et al. Adiponectin is associated with increased mortality and heart failure in patients with stable ischemic heart disease: data from the Heart and Soul Study. Atherosclerosis 2012;220(2):587-92
   PubMed Web of Science ®Google Scholar
• Kizer JR, Benkeser D, Arnold AM, et al. Associations of total and high-molecular-weight adiponectin with all-cause and cardiovascular mortality in older persons: the Cardiovascular Health Study. Circulation 2012;126(25):2951-61
   PubMedGoogle Scholar
• Goldberg IJ, Huang LS, Huggins LA, et al. Thyroid hormone reduces cholesterol via a non-LDL receptor-mediated pathway. Endocrinology 2012;153(11):5143-9
   PubMedGoogle Scholar
• Chin KY, Ima-Nirwana S, Mohamed IN, et al. The relationships between thyroid hormones and thyroid-stimulating hormone with lipid profile in euthyroid men. Int J Med Sci 2014;11(4):349-55
   PubMedGoogle Scholar
• Kasiske BL, Ma JZ, Kalil RS, Louis TA. Effects of antihypertensive therapy on serum lipids. Ann Intern Med 1995;122(2):133-41
   PubMed Web of Science ®Google Scholar
• Keen-Rhinehart E, Ondek K, Schneider JE. Neuroendocrine regulation of appetitive ingestive behavior. Front Neurosci 2013;7:213
   PubMedGoogle Scholar
• Maffei M, Halaas J, Ravussin E, et al. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1995;1(11):1155-61
   PubMed Web of Science ®Google Scholar
• Considine RV, Sinha MK, Heiman ML, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996;334(5):292-5
   PubMed Web of Science ®Google Scholar
• Donahoo WT, Stob NR, Ammon S, et al. Leptin increases skeletal muscle lipoprotein lipase and postprandial lipid metabolism in mice. Metabolism 2011;60(3):438-43
   PubMedGoogle Scholar
• Zuo H, Shi Z, Yuan B, et al. Association between serum leptin concentrations and insulin resistance: a population-based study from China. PLoS One 2013;8(1):e54615
   PubMed Web of Science ®Google Scholar
• Koh KK, Quon MJ, Lee SJ, et al. Efonidipine simultaneously improves blood pressure, endothelial function, and metabolic parameters in nondiabetic patients with hypertension. Diabetes Care 2007;30(6):1605-7
   PubMedGoogle Scholar
• Rutter MK, Sattar N, Tajar A, et al. Epidemiological evidence against a role for C-reactive protein causing leptin resistance. Eur J Endocrinol 2013;168(1):101-6
   PubMedGoogle Scholar
• Guarente L. Calorie restriction and sirtuins revisited. Genes Dev 2013;27(19):2072-85
   PubMed Web of Science ®Google Scholar
• Stewart TM, Bhapkar M, Das S, et al. Comprehensive Assessment of Long-term Effects of Reducing Intake of Energy Phase 2 (CALERIE Phase 2) screening and recruitment: methods and results. Contemp Clin Trials 2013;34(1):10-20
   PubMed Web of Science ®Google Scholar
• Rickman AD, Williamson DA, Martin CK, et al. The CALERIE Study: design and methods of an innovative 25% caloric restriction intervention. Contemp Clin Trials 2011;32(6):874-81
   PubMed Web of Science ®Google Scholar
• Fontana L, Meyer TE, Klein S, Holloszy JO. Long-term calorie restriction is highly effective in reducing the risk for atherosclerosis in humans. Proc Natl Acad Sci U S A 2004;101(17):6659-63
   PubMed Web of Science ®Google Scholar
• Koppo K, Siklová-Vitková M, Klimcáková E, et al. Catecholamine and insulin control of lipolysis in subcutaneous adipose tissue during long-term diet-induced weight loss in obese women. Am J Physiol Endocrinol Metab 2012;302(2):E226-32
   Google Scholar
• Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Arterioscler Thromb Vasc Biol 2004;24(8):e149-61
   PubMed Web of Science ®Google Scholar
• Manson JE, Chlebowski RT, Stefanick ML, et al. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women’s Health Initiative randomized trials. JAMA 2013;310(13):1353-68
   PubMed Web of Science ®Google Scholar
• Sumino H, Murakami M. [Investigation of atherosclerosis in postmenopausal women: alteration of atherosclerosis-associated factors and vascular atherosclerosis by oral and transdermal estrogen replacement]. Rinsho Byori 2013;61(3):256-62
   PubMedGoogle Scholar
• Rossouw JE, Prentice RL, Manson JE, et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007;297(13):1465-77
   PubMed Web of Science ®Google Scholar
• Izzicupo P, Ghinassi B, D’Amico MA, et al. Effects of ACE I/D polymorphism and aerobic training on the immune-endocrine network and cardiovascular parameters of postmenopausal women. J Clin Endocrinol Metab 2013;98(10):4187-94
   PubMedGoogle Scholar